Trials / Completed
CompletedNCT01075256
Dose Response of a Tubule Occlusion Agent
An Exploratory Clinical Study to Evaluate the Efficacy of Two Currently Marketed Toothpastes Containing Different Concentrations of a Tubule Occlusion Agent
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 195 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of two different concentrations of a tubule occlusion agent - calcium sodium phosphosilicate in treatment of dentine hypersensitivity
Detailed description
Dentine hypersensitivity is characterized by short, sharp pain arising from exposed dentine typically in response to chemical, thermal, tactile or osmotic stimuli. Dentine hypersensitivity may be treated by either making the nerve in the tooth less sensitive or by occluding the tubules to limit exposure of the nerve to external stimuli. Bioactive and biocompatible glasses react with oral fluid to deposit a mineral that is chemically analogous to that found in both enamel and dentine thus preventing exposure of the nerve to external stimuli. A number of controlled clinical trials have been reported indicating that a calcium sodium phosphosilicate bioactive glass, when incorporated into a toothpaste formulation, significantly reduce pain from dentine hypersensitivity. The aim of this study is to evaluate the effectiveness of two currently marketed toothpastes, containing 5% calcium sodium phosphosilicate and the other containing 7.5% calcium sodium phosphosilicate in the treatment of dentine hypersensitivity compared to a matched placebo control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 5% calcium sodium phosphosilicate toothpaste | Low concentration calcium sodium phosphosilicate tubule occlusion agent |
| DEVICE | 7.5% calcium sodium phosphosilicate toothpaste | High concentration calcium sodium phosphosilicate tubule occlusion agent |
| DEVICE | Placebo toothpaste | Placebo toothpaste |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2010-02-25
- Last updated
- 2013-06-03
- Results posted
- 2013-06-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01075256. Inclusion in this directory is not an endorsement.